Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2013 Mar 31;71(6):1531–1540. doi: 10.1007/s00280-013-2152-7

Figure 3.

Figure 3

Numbness reported in: A, patients with (n=11) and without (n=44) sharpness detection deficits during induction therapy; B, patients with (n=3) and without (n=12) sharpness detection deficits during maintenance therapy; C, patients with (n=5) and without (n=8) warmth detection deficits during maintenance therapy; D, patients with (n=5) and without (n=8) warmth detection deficits during maintenance therapy.